IntraLinks Connect helps deliver new drugs and treatments to the market faster.
Leading clinical research organizations (CROs), biotechnology firms, and pharmaceutical and medical device companies rely on IntraLinks to securely exchange information both inside and outside of the firewall to secure funding for research and development and streamline third party document collaboration. IntraLinks drives efficiency in all phases of drug lifecycle development by reducing the amount of paper that changes hands and eliminating manual processes.
IntraLinks solutions are designed to provide the fastest, most secure way to manage critical information that supports bringing new drugs and therapies to the market. Automated workflows help to move critical documents from one phase to the next, easing the flow of information between organizations and saving time. In addition, audit and reporting capabilities support transparency and compliance, which leads to faster approvals by regulatory agencies.
